CAMBRIDGE, Mass., Aug. 6, 2013 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) announced today that the Company's second quarter 2013 financial results will be released before market open on Wednesday, August 7, 2013. Idenix management will host a conference call at 8:00 a.m. ET on Wednesday, August 7, 2013, to discuss the company's financial results for the second quarter of 2013 and provide an update on the company's development programs. To access the call, please dial (877) 640-9809 (U.S./Canada) or (914) 495-8528 (International) and enter passcode 20505896. A live webcast will be available through the Investor section of the Idenix website at www.idenix.com under "Events & Presentations". The archived webcast will be available for two weeks following the call on the Idenix website. About Idenix Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical Company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix's current focus is on the treatment of patients with HCV infection. For further information about Idenix, please refer to www.idenix.com.
CONTACT: Idenix Pharmaceuticals Contact: Teri Dahlman (617) 995-9807